Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000108

Chairperson & CEO sold 9,500 shares at an average $526.73 ($5,003,976)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-28 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-28 Sale : show line 2 in the form 10b5-1 −1,367 $523.15 $715,152 332,576 I
2026-07-28 Sale : show line 3 in the form 10b5-1 −1,074 $524.04 $562,818 331,502 I
2026-07-28 Sale : show line 4 in the form 10b5-1 −876 $525.02 $459,918 330,626 I
2026-07-28 Sale : show line 5 in the form 10b5-1 −1,473 $526.34 $775,295 329,153 I
2026-07-28 Sale : show line 6 in the form 10b5-1 −1,369 $527.16 $721,678 327,784 I
2026-07-28 Sale : show line 7 in the form 10b5-1 −1,149 $528.20 $606,905 326,635 I
2026-07-28 Sale : show line 8 in the form 10b5-1 −625 $529.41 $330,882 326,010 I
Open-market sales · 9,500 sh · avg $526.73 · $5,003,976

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-28 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option −9,500 255,910 I
Loading xslF345X06/primarydocument.xml…